GFAFX
Price
$76.19
Change
-$0.14 (-0.18%)
Updated
Sep 20 closing price
RAFGX
Price
$45.26
Change
-$0.07 (-0.15%)
Updated
Sep 20 closing price
Ad is loading...

GFAFX vs RAFGX

Header iconGFAFX vs RAFGX Comparison
Open Charts GFAFX vs RAFGXBanner chart's image
American Funds Growth Fund of Amer F1
Price$76.19
Change-$0.14 (-0.18%)
VolumeN/A
CapitalizationN/A
American Funds AMCAP R6
Price$45.26
Change-$0.07 (-0.15%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GFAFX vs RAFGX Comparison Chart
Loading...
VS
GFAFX vs. RAFGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFAFX is a StrongBuy and RAFGX is a Buy.

FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 290B vs. RAFGX (89.3B). RAFGX pays higher dividends than GFAFX: RAFGX (0.98) vs GFAFX (0.45). GFAFX was incepted earlier than RAFGX: GFAFX (24 years) vs RAFGX (15 years). GFAFX (31.00) and RAFGX (31.00) have comparable annual turnover. GFAFX (250) and RAFGX (250) have matching initial minimum investment requirements. GFAFX (30.09) and RAFGX (29.22) have marching annual gain over last year. GFAFX return over 5 years is better than : 53.60 vs. RAFGX (41.37).
GFAFXRAFGXGFAFX / RAFGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years15 years-
Gain YTD21.69016.200134%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets290B89.3B325%
Annual Yield % from dividends0.450.9847%
Returns for 1 year30.0929.22103%
Returns for 3 years0.462.0223%
Returns for 5 years53.6041.37130%
Returns for 10 years68.2459.18115%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYY75.191.05
+1.42%
Sysco Corp
SGC15.04-0.33
-2.15%
Superior Group of Companies
FIVN27.75-0.73
-2.56%
Five9
INSG17.64-0.47
-2.60%
Inseego Corp
MRVI8.44-0.40
-4.52%
Maravai LifeSciences Holdings